Immunization against Pseudomonas aeruginosa: the effects of serotype and virulence in mouse protection tests

Real-world outcomes with durvalumab after chemoradiotherapy in patients with unresectable stage III NSCLC: interim analysis of overall survival from PACIFIC-R.

ESMO open·2024

Phase I safety, pharmacokinetic, and pharmacodynamic study of the oral phosphatidylinositol-3-kinase and mTOR inhibitor BGT226 in patients with advanced solid tumors.

Annals of oncology : official journal of the European Society for Medical Oncology·2012

PI3K inhibition results in enhanced HER signaling and acquired ERK dependency in HER2-overexpressing breast cancer.

Oncogene·2011

Biomarkers in colorectal cancer.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·2010

Status of PI3K inhibition and biomarker development in cancer therapeutics.

Annals of oncology : official journal of the European Society for Medical Oncology·2009